MT VET COBRE PROJECT 2: METAL UPTAKE AND REGULATION IN STREPTOCOCCUS PYOGENES
MT VET COBRE 项目 2:化脓性链球菌的金属吸收和调节
基本信息
- 批准号:7721026
- 负责人:
- 金额:$ 17.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:BacteriaBindingCellsComputer Retrieval of Information on Scientific Projects DatabaseDiseaseErythrocytesFundingGrantGrowthHemeHemoglobinHumanInfectious Skin DiseasesInstitutionIronMammalsMembrane ProteinsMetalsModelingPathway interactionsPharyngeal structureProcessProteinsRegulationResearchResearch PersonnelResourcesRoleSourceStaphylococcus aureusStreptococcus pyogenesToxic Shock SyndromeUnited States National Institutes of Healthhuman tissuenovel therapeuticspathogenuptake
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The bacteria known as Streptococcus pyogenes and Staphylococcus aureus are important human pathogens that cause a variety of diseases, including strep throat, toxic shock syndrome, and/or skin infection. These bacteria require iron for growth. However, free iron is quite scarce in human tissues, and bacteria have developed several approaches for acquiring the iron needed for their growth. The majority of iron in mammals is heme, which is present in some proteins. For example, one of the most common heme-containing proteins in humans is hemoglobin from red blood cells. To obtain iron, bacteria have developed approaches for acquiring heme from host proteins and internalizing it, which is degraded to provide bacterial cells with the needed iron. The heme acquisition machineries in Streptococcus pyogenes and Staphylococcus aureus consist of surface proteins and a transmembrane transporter. However, the specific pathway and mechanism of the heme acquisition process are not well understood. The roles of the surface proteins of Streptococcus pyogenes and Staphylococcus aureus in the heme acquisition process by these bacteria have been studied. The surface protein Shr of Streptococcus pyogenes binds heme, and the other surface protein Shp relays heme from Shr to the transmembrane transporter. It also has been demonstrated that the surface protein IsdA of Staphylococcus aureus directly and rapidly transfers its heme to the other surface protein IsdC. These studies suggest that these surface proteins relay heme from host proteins to the transporter for subsequent internalization. These results greatly enhance our understanding of the mechanisms of heme acquisition in Streptococcus pyogenes and Staphylococcus aureus and may serve as a general model for heme acquisition in many other Gram-positive pathogens. Understanding of how these bacteria utilize heme to survive in humans may provide clues on how to block the heme transport for developing new therapeutics to combat these harmful pathogens.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目及
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
化脓性链球菌和金黄色葡萄球菌是重要的人类病原体,可引起多种疾病,包括链球菌性咽喉炎、中毒性休克综合征和/或皮肤感染。 这些细菌的生长需要铁。 然而,人体组织中的游离铁相当稀缺,细菌已经开发出多种方法来获取其生长所需的铁。 哺乳动物中的大部分铁是血红素,它存在于一些蛋白质中。 例如,人类最常见的含血红素蛋白质之一是来自红细胞的血红蛋白。 为了获得铁,细菌已经开发出从宿主蛋白质中获取血红素并将其内在化的方法,血红素被降解以为细菌细胞提供所需的铁。 化脓性链球菌和金黄色葡萄球菌的血红素获取机制由表面蛋白和跨膜转运蛋白组成。 然而,血红素获取过程的具体途径和机制尚不清楚。 已经研究了化脓性链球菌和金黄色葡萄球菌的表面蛋白在这些细菌获取血红素过程中的作用。 化脓性链球菌的表面蛋白 Shr 与血红素结合,另一种表面蛋白 Shp 将血红素从 Shr 传递到跨膜转运蛋白。 还证明金黄色葡萄球菌的表面蛋白IsdA可以直接且快速地将其血红素转移到另一种表面蛋白IsdC上。 这些研究表明这些表面蛋白将血红素从宿主蛋白传递到转运蛋白以进行随后的内化。 这些结果极大地增强了我们对化脓性链球菌和金黄色葡萄球菌血红素获取机制的理解,并可作为许多其他革兰氏阳性病原体中血红素获取的通用模型。 了解这些细菌如何利用血红素在人体中生存,可能会为如何阻止血红素运输提供线索,从而开发新的疗法来对抗这些有害病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENFANG LEI其他文献
BENFANG LEI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENFANG LEI', 18)}}的其他基金
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10171774 - 财政年份:2020
- 资助金额:
$ 17.99万 - 项目类别:
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10040605 - 财政年份:2020
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8297945 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8604673 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
9001240 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8788345 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8371028 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8417645 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8495257 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
MT VET COBRE PROJECT 2: HEME UPTAKE PATHWAYS IN GRAM-POSITIVE PATHOGENS
MT VET COBRE 项目 2:革兰氏阳性病原体中的血红素摄取途径
- 批准号:
7960526 - 财政年份:2009
- 资助金额:
$ 17.99万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Oral pathogen - mediated pro-tumorigenic transformation through disruption of an Adherens Junction - associated RNAi machinery
通过破坏粘附连接相关的 RNAi 机制,口腔病原体介导促肿瘤转化
- 批准号:
10752248 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
DRUG DISCOVERY BY DIRECTED EVOLUTION IN MAMMALIAN CELLS
通过哺乳动物细胞定向进化发现药物
- 批准号:
10644749 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别: